Frank McCormick insider trades
Open-market stock purchases and sales by Frank McCormick, Director at BridgeBio Pharma, Inc, from SEC Form 4 filings since May 19, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Jun 16, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Bought (not open market) | — |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $7.3M |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $2.1M |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $236K |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $589K |
| Oct 29, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $3M |
| Oct 27, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $107K |
Companies traded
- BBIO BridgeBio Pharma, Inc: 22 sales, last Jun 22, 2026
- BBOT BridgeBio Oncology Therapeutics, Inc: other filings, last Jun 16, 2026
- OLMA Olema Pharmaceuticals, Inc: other filings, last Nov 23, 2020
- ADRO Aduro Biotech, Inc: other filings, last Jun 6, 2018
- EXEL Exelixis, Inc: other filings, last Dec 6, 2013